Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV002410691 | SCV002719765 | likely pathogenic | Hereditary cancer-predisposing syndrome | 2024-06-24 | criteria provided, single submitter | clinical testing | The c.-191T>G variant is located in the 5' untranslated region (5’ UTR) of the APC gene. This variant results from a T to G substitution 191 bases upstream from the first translated codon. This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) (Ambry internal data; Roberts AG et al. JPGN Reports, 2021 Nov;2(4):e123; Ishida A et al. Clin J Gastroenterol . 2024 Apr). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Another alteration at the same position, (c.-191T>C), has been detected in multiple families with clinical diagnoses of GAPPS, shown to be a part of a highly conserved transcription factor binding site, and shown to have significantly decreased transcriptional activity in luciferase-based functional studies (Ambry internal data, Li J et al. Am J Hum Genet 2016 05;98(5):830-842). This nucleotide position is highly conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic. |